36
M. García-Valverde et al.
LETTER
crystallographic data for this paper. These data can be
retrieving.html or from the Cambridge Crystallographic
Data Centre, 12, Union Road, Cambridge CB2 1EZ, UK;
fax: +44(1223)336033; email: deposit@ccdc.cam.ac.uk.
(11) (a) Pirrung, M. C.; Das Sarma, K. J. Am. Chem. Soc. 2004,
126, 444. (b) See also: Mironov, M. A.; Ivantsova, M. N.;
Mokrushin, V. S. Mol. Divers. 2003, 6, 193.
(12) Synthesis of Deacylated Ugi Products 7a–c; General
Procedure: A mixture of p-chlorophenylglyoxal (169 mg,
1 mmol) and the corresponding arylamine (1 mmol) in
i-Pr2O (10 mL) was stirred at r.t. for 10 min. Then cyclo-
hexyl isocyanide (110 mg, 1 mmol) and anhyd trichloro-
acetic acid (163 mg, 1 mmol) were consecutively added and
the mixture was stirred at r.t. for 2 d. The solid residue was
filtered and then recrystallized from the i-Pr2O–i-PrOH
mixture.
126.1 (Cq), 126.3 (CHAr), 128.5 (CHAr), 128.7 (CHAr), 129.4
(CHAr), 129.6 (CHAr), 133.7 (Cq), 139.1 (Cq), 152.5 (Cq),
157.1 (Cq). IR (KBr): 3254, 1770, 1630 cm–1. MS (EI): m/z
(%) = 362 (69) [M+], 279 (100). HRMS (EI): m/z calcd for
C22H22N2O3: 362.1630; found: 362.1632. Anal. Calcd for
C22H22N2O3: C, 72.91; H, 6.12; N, 7.73. Found: C, 72.97; H,
6.16; N, 7.67.
3-(4-Chlorophenyl)-N-cyclohexyl-2-oxo-5-p-tolyl-2,3-
dihydrooxazole-4-carboxamide (5g): colorless crystals
(284 mg, 69%); mp 232–233 °C (i-Pr2O–i-PrOH). 1H NMR
(400 MHz, CDCl3): d = 0.93–1.10 (m, 3 H), 1.20–1.34 (m, 2
H), 1.55–1.63 (m, 3 H), 1.75–1.79 (m, 2 H), 2.39 (s, 3 H),
3.75–3.84 (m, 1 H), 5.61 (d, J = 8.2 Hz, 1 H), 7.22–7.25 (m,
2 H), 7.32–7.35 (m, 2 H), 7.40–7.44 (m, 2 H), 7.57–7.59 (m,
2 H). 13C NMR (100 MHz, CDCl3): d = 21.7 (Me), 24.8
(CH2), 25.4 (CH2), 32.6 (CH2), 49.0 (CH), 118.4 (Cq), 123.3
(Cq), 126.9 (CHAr), 127.1 (CHAr), 129.7 (CHAr), 129.8
(CHAr), 132.8 (Cq), 134.4 (Cq), 140.0 (Cq), 140.7 (Cq), 152.7
(Cq), 157.2 (Cq). IR (KBr): 3282, 1774, 1663, 1635, 1495
cm–1. MS (EI): m/z (%) = 412 (16) [M+ + 2], 410 (57) [M+],
327 (84), 119 (100). HRMS (EI): m/z calcd for
3-(4-Chlorophenyl)-N-cyclohexyl-3-oxo-2-(phenyl-
amino)propionamide (7a): colorless crystals (130 mg,
35%); mp 164–165 °C (i-Pr2O–i-PrOH). 1H NMR (400
MHz, CDCl3): d = 0.89–1.13 (m, 3 H), 1.20–1.32 (m, 2 H),
1.48–1.83 (m, 5 H), 3.57–3.68 (m, 1 H), 5.31 (d, J = 3.0 Hz,
1 H), 5.43 (d, J = 3.0 Hz, 1 H), 6.68–6.71 (m, 2 H), 6.80–6.85
(m, 2 H), 7.21–7.24 (m, 2 H), 7.44–7.46 (m, 2 H), 8.21–8.23
(m, 2 H). 13C NMR (100 MHz, CDCl3): d = 24.5 (CH2), 24.6
(CH2), 25.2 (CH2), 32.4 (CH2), 32.5 (CH2), 48.6 (CH), 66.6
(CH), 113.8 (CHAr), 119.4 (CHAr), 128.7 (CHAr), 129.5
(CHAr), 131.8 (CHAr), 132.3 (Cq), 140.9 (Cq), 145.5 (Cq),
165.8 (Cq), 193.0 (Cq). IR (KBr): 3390, 3298, 1695, 1654
cm–1. MS (EI): m/z (%) = 372 (7) [M+ + 2], 370 (24) [M+],
245 (100), 231 (99), 104 (69). HRMS (EI): m/z calcd for
C21H23ClN2O2: 370.1448; found: 370.1443. Anal. Calcd for
C21H23ClN2O2: C, 68.01; H, 6.25; N, 7.55. Found: C, 67.94;
H, 5.95; N, 7.48.
C23H23ClN2O3: 410.1397; found: 410.1382. Anal. Calcd for
C23H23ClN2O3: C, 67.23; H, 5.64; N, 6.82. Found: C, 67.28;
H, 5.67; N, 6.77.
5-(4-Chlorophenyl)-N-cyclohexyl-2-oxo-3-phenyl-2,3-
dihydrooxazole-4-carboxamide (5h): colorless crystals
(349 mg, 88%); mp 224–226 °C (dec., i-Pr2O–i-PrOH). 1H
NMR (400 MHz, CDCl3): d = 0.78–0.88 (m, 2 H), 0.98–1.08
(m, 1 H), 1.18–1.30 (m, 2 H), 1.51–1.68 (m, 5 H), 3.71–3.79
(m, 1 H), 5.37 (d, J = 8.0 Hz, 1 H), 7.38–7.49 (m, 7 H), 7.75–
7.77 (m, 2 H). 13C NMR (100 MHz, CDCl3): d = 24.6 (CH2),
25.4 (CH2), 32.5 (CH2), 48.9 (CH), 119.5 (Cq), 125.0 (Cq),
125.9 (CHAr), 128.0 (CHAr), 129.0 (CHAr), 129.2 (CHAr),
129.9 (CHAr), 131.7 (Cq), 133.9 (Cq), 135.9 (Cq), 139.2 (Cq),
152.5 (Cq), 157.1 (Cq). IR (KBr): 3305, 1789, 1658, 1632
cm–1. MS (EI): m/z (%) = 398 (24) [M+ + 2], 396 (100) [M+],
313 (59), 315 (19). HRMS (EI): m/z calcd for C22H21ClN2O3:
396.1241; found: 396.1233. Anal. Calcd for C22H21ClN2O3:
C, 66.58; H, 5.33; N, 7.06. Found: C, 66.53; H, 5.29; N, 7.01.
3-(3-Chlorophenyl)-N-cyclohexyl-5-(4-methoxyphenyl)-
2-oxo-2,3-dihydrooxazole-4-carboxamide (5l): colorless
crystals (265 mg, 62%); mp 240–241 °C (dec., i-Pr2O–i-
PrOH). 1H NMR (400 MHz, CDCl3): d = 0.86–1.30 (m, 5 H),
1.53–1.61 (m, 3 H), 1.75–1.79 (m, 2 H), 3.77–3.83 (m, 1 H),
3.85 (s, 3 H), 5.49 (d, J = 8.4 Hz, 1 H), 6.94–6.96 (m, 2 H),
7.32–7.41 (m, 4 H), 7.67–7.69 (m, 2 H). 13C NMR (100
MHz, CDCl3): d = 24.7 (CH2), 25.4 (CH2), 32.6 (CH2), 48.9
(CH), 55.6 (Me), 114.5 (CHAr), 117.5 (Cq), 118.6 (Cq), 123.9
(CHAr), 126.0 (CHAr), 128.7 (CHAr), 128.8 (CHAr), 130.5
(CHAr), 135.2 (Cq), 152.5 (Cq), 157.2 (Cq), 161.2 (Cq). IR
(KBr): 3418, 3247, 1773, 1661, 1632, 1607 cm–1. MS (EI):
m/z (%) = 428 (13) [M+ + 2], 426 (47) [M+], 135 (100).
HRMS (EI): m/z calcd for C23H23ClN2O4: 426.1346; found:
426.1329. Anal. Calcd for C23H23ClN2O4: C, 64.71; H, 5.43;
N, 6.56. Found: C, 64.66; H, 5.38; N, 6.51.
(13) For a complete discussion about the effect of reagents and
solvents in the Ugi reaction, see: Marcaccini, S.; Torroba, T.
Nature Prot. 2007, 2, 632.
(14) Synthesis of N-Cyclohexyl-3-oxo-3-p-tolyl-2-(2,2,2-
trichloro-N-p-tolylacetamido)propionamide (6e): A
mixture of p-tolylglyoxal (148 mg, 1 mmol) and p-toluidine
(107 mg, 1 mmol) in MeOH (10 mL) was stirred for 10 min,
and then cyclohexyl isocyanide (110 mg, 1 mmol) and anhyd
trichloroacetic acid (327 mg, 2 mmol) were consecutively
added. The mixture was stirred at r.t. for 3 d, cooled at 0 °C
overnight, then filtered, and the collected solid was recrys-
tallized from MeOH, from which product 6e was obtained as
colorless crystals (347 mg, 68%); mp 210–212 °C (MeOH).
1H NMR (400 MHz, CDCl3): d = 0.73–1.28 (m, 5 H), 1.65–
1.41 (m, 5 H), 2.34 (s, 3 H), 2.42 (s, 3 H), 3.50–3.61 (m, 1
H), 6.10 (d, J = 7.8 Hz, 1 H), 6.27 (s, 1 H), 7.10 (d, J = 8.5
Hz, 2 H), 7.28 (d, J = 8.1 Hz, 2 H), 7.39 (d, J = 8.5 Hz, 2 H),
7.86 (d, J = 8.1 Hz, 2 H). 13C NMR (100 MHz, CDCl3): d =
21.2 (Me), 21.8 (Me), 24.4 (CH2), 24.5 (CH2), 25.3 (CH2),
32.0 (CH2), 32.3 (CH2), 48.6 (CH), 71.1 (CH), 93.0 (Cq),
127.8 (Cq), 128.5 (CHAr), 129.0 (CHAr), 129.6 (CHAr), 131.2
(CHAr), 132.9 (Cq), 135.8 (Cq), 139.7 (Cq), 145.2 (Cq), 161.1
(Cq), 162.8 (Cq), 194.1 (Cq). IR (KBr): 3242, 1771, 1631,
744 cm–1. MS (EI): m/z (%) = 512 (0.7) [M+ + 4], 510 (3.4)
[M+ + 2], 508 (2.5) [M+], 391 (27), 390 (100), 307 (45), 119
(92). HRMS (EI): m/z calcd for C25H27Cl3N2O3: 508.1056;
found: 508.1087. Anal. Calcd for C25H27Cl3N2O3: C, 58.89;
H, 5.34; N, 5.49. Found: C, 58.83; H, 5.28; N, 5.43.
(10) Crystal Data for Compound 5b: C23H24N2O3, MW =
376.44, orthorhombic, P212121, a = 9.038(5) Å, b = 10.536
(5) Å, c = 21.916(11) Å, a = 90°, b = 90°, g = 90°; V =
2087.1(18) Å3, Z = 4, Dcalc = 1.198 gcm–1, m(Mo–Ka) = 0.080
mm–1. Colorless prism (0.30 × 0.20 × 0.10 mm3), 19410
measured reflections, 3658 independent (Rint = 0.0968),
2247 observed [I > 2s(I)]. R1 = 0.1434, wR2 = 0.2444 (all
data). CCDC 664815 contains the supplementary
Synlett 2008, No. 1, 33–36 © Thieme Stuttgart · New York